Table 1 summarizes the clinical and genetic characteristics, treatment regimens, and outcomes of 15 patients with NSCLC with co-occurring EGFR and CTNNB1 mutations in the single-center cohort. This evidence concerns the gene CTNNB1 and non-small cell lung carcinoma.